Search results for "MC"

showing 10 items of 2122 documents

Orthopaedic manual therapy, McKenzie method or advice only for low back pain in working adults: a randomized controlled trial with one year follow-up.

2009

OBJECTIVE: To examine the effects of 2 manual therapy methods compared with one counselling session with a physiotherapist with "advice-only to stay active" for treating low back pain/leg pain and disability. DESIGN: A randomized, controlled trial with a 1-year follow-up. SUBJECTS: A total of 134 subjects with low back disorders. METHODS: Participants with acute to chronic first or recurrent low back pain, excluding those with "red flag" criteria, were assigned randomly to one of the 3 intervention groups: an orthopaedic manual therapy group (n=45), a McKenzie method group (n=52), and an "advice only to be active" group (advice-only) (n=37). Data on leg and low back pain intensity and disab…

AdultMalemedicine.medical_specialtyOne year follow upAdolescentPhysical Therapy Sports Therapy and Rehabilitationlaw.inventionDisability EvaluationYoung AdultPhysical medicine and rehabilitationRandomized controlled trialPatient Education as TopiclawRecurrenceOutcome Assessment Health CaremedicineBack painHumansYoung adultPhysical Therapy ModalitiesAgedbusiness.industryRehabilitationGeneral MedicineMiddle AgedLow back painMusculoskeletal ManipulationsConfidence intervalChronic DiseasePhysical therapyMcKenzie methodFemalemedicine.symptomManual therapybusinessLow Back PainFollow-Up StudiesJournal of rehabilitation medicine
researchProduct

Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safet…

2007

Background: In daily clinical practice second-line chemotherapy (SLCT) is frequently given to patients with advanced pancreatic cancer failing gemcitabine-based first-line chemotherapy without solid scientific support. Patients and methods: A retrospective survey was carried out including 42 patients. Patients received standard FOLFOX4 regimen biweekly until progression or unacceptable toxicity. Results: Six partial responses (14%) and 16 stabilizations (38%) were recorded for a tumor growth control rate of 57%. The median time to progression (TtP) was 4 months (range 1–7 months), and median overall survival (OS) was 6.7 months (range 2–9 months). A stabilization of performance status (PS) …

AdultMalemedicine.medical_specialtyPancreatic diseaseOrganoplatinum Compoundsmedicine.medical_treatmentLeucovorinAdenocarcinomaInternal medicinePancreatic cancerAntineoplastic Combined Chemotherapy ProtocolsMedicineHumansAgedRetrospective StudiesChemotherapyPerformance statusbusiness.industryCancerHematologyMiddle Agedmedicine.diseaseChemotherapy regimenGemcitabineDrug Resistance MultipleSurgeryPancreatic NeoplasmsFOLFOX4 regimen pancreatic carcinoma second-line chemotherapyRegimenOncologyChemotherapy AdjuvantDrug Resistance NeoplasmFemaleFluorouracilbusinessmedicine.drug
researchProduct

Increased proportion of comorbidities but no deterioration of sexual quality of life during a 5-year follow-up in patients with axial spondyloarthrit…

2021

Abstract Objective To explore patient perception of sexual quality of life (SQOL), an important category of QOL, in male and female patients with axial SpA (axSpA) after a 5 year follow-up. Methods A broad spectrum of demographic, disease-related, treatment and SQOL data was collected at baseline and at the 5 year follow-up. SQOL was assessed by the SQOL-Female (SQOL-F) questionnaire. For statistical analysis, McNemar’s tests, paired t-tests and multiple regression analyses were applied. Results A total of 245 axSpA patients (168 men and 77 women) from outpatient clinics were examined (mean age 46 years, mean disease duration 11.9 years at baseline). Compared with baseline, the patients had…

AdultMalemedicine.medical_specialtySexual BehaviorDiseaseComorbidityMcNemar's testRheumatologyQuality of lifeInternal medicineSurveys and QuestionnairesSpondylarthritismedicineOutpatient clinicHumansPharmacology (medical)Axial spondyloarthritisAnkylosing spondylitisBiological Productsbusiness.industryEnthesitisMiddle Agedmedicine.diseaseComorbidityAntirheumatic AgentsQuality of LifeFemalemedicine.symptombusinessFollow-Up StudiesRheumatology (Oxford, England)
researchProduct

Lifetime, 5-year and past-year prevalence of homelessness in Europe: a cross-national survey in eight European nations

2019

ObjectivesTo examine the lifetime, 5-year and past-year prevalence of homelessness among European citizens in eight European nations.DesignA nationally representative telephone survey using trained bilingual interviewers and computer-assisted telephone interview software.SettingThe study was conducted in France, Ireland, Italy, the Netherlands, Poland, Portugal, Spain and Sweden.ParticipantsEuropean adult citizens, selected from opt-in panels from March to December 2017. Total desired sample size was 5600, with 700 per country. Expected response rates of approximately 30% led to initial sample sizes of 2500 per country.Main outcome measuresHistory of homelessness was assessed for lifetime, …

AdultMalemedicine.medical_specialtyTime FactorsAdolescent[SDV]Life Sciences [q-bio]prevalenceService useSociodemographic dataHealthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18]03 medical and health sciencesHealth servicesYoung Adult0302 clinical medicineRisk FactorsSurveys and QuestionnairesmedicineHumans1724030212 general & internal medicine150610. No inequalitySociodemographic datahomelessnessAgedOriginal ResearchAged 80 and overbusiness.industryeuropean adult citizensEurope; homelessness; prevalence; public healthCross national surveyPublic health1. No povertyGeneral MedicineMiddle Aged3. Good healthTelephone surveyEuropeTelephone interviewSocioeconomic FactorsSample size determinationIll-Housed PersonsLinear ModelsFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiePublic Healthbusiness030217 neurology & neurosurgeryDemographyBMJ Open
researchProduct

Eye Pain and Dry Eye in Patients with Fibromyalgia.

2018

Objectives The aim of this study was to examine visual function and eye symptoms in fibromyalgia patients, with a particular focus on dry eye syndrome and eye pain. Methods A tertiary care center-based cross-sectional study was carried out in chronic musculoskeletal pain patients diagnosed with fibromyalgia. Chronic musculoskeletal pain patients without fibromyalgia were enrolled as a comparison group. Self-reported eye pain was investigated with the McGill pain questionnaire and the numeric rating scale. In addition, we assessed corrected visual acuity, vision-related quality of life, and self-reported dry eye syndrome. Results A total of 90 musculoskeletal pain patients were included, wit…

AdultMalemedicine.medical_specialtyVisual acuityFibromyalgiagenetic structuresCross-sectional studyDry Eye Syndromes03 medical and health sciences0302 clinical medicineQuality of lifeInternal medicineFibromyalgiamedicinePrevalenceEye PainHumans030203 arthritis & rheumatologybusiness.industryChronic painGeneral MedicineMiddle Agedmedicine.diseaseeye diseasesRheumatologyAnesthesiology and Pain MedicineCross-Sectional StudiesMcGill Pain Questionnaire030221 ophthalmology & optometryPhysical therapyQuality of LifeDry Eye SyndromesFemaleNeurology (clinical)medicine.symptomChronic PainbusinessPain medicine (Malden, Mass.)
researchProduct

Therapeutic aquatic exercise in the treatment of low back pain: a systematic review.

2008

Objective: To examine the effectiveness of therapeutic aquatic exercise in the treatment of low back pain. Design: A systematic review. Methods: A search was performed of PEDro, CINAHL (ovid), PUBMED, Cochrane Controlled Trials Register and SPORTDiscus databases to identify relevant studies published between 1990 and 2007. Population: Adults suffering from low back pain. Intervention: All types of therapeutic aquatic exercise. Comparison: All clinical trials using a control group. Outcomes: Oswestry Disability Index, McGill Pain Questionnaire, subjective assessment scale for pain (e.g. visual analogue scale) and number of work days lost as a direct result of low back pain. Methodological q…

AdultMalemedicine.medical_specialtyVisual analogue scalemedicine.medical_treatmentPopulationPhysical Therapy Sports Therapy and RehabilitationCINAHLPhysical medicine and rehabilitationPregnancymedicineHumanseducationHydrotherapySwimmingHydrotherapyeducation.field_of_studybusiness.industryRehabilitationLow back painOswestry Disability IndexExercise TherapyClinical trialPregnancy ComplicationsMcGill Pain QuestionnairePhysical therapyFemalemedicine.symptombusinessLow Back PainClinical rehabilitation
researchProduct

Gemcitabine and cisplatin for inoperable and/or metastatic biliary tree carcinomas: a multicenter phase II study of the Gruppo Oncologico dell'Italia…

2006

Background The aim of the study was to test the clinical efficacy and toxicity profile of gemcitabine (GEM) in combination with cisplatin (CDDP) in a series of patients affected by unresectable and/or metastatic biliary tree carcinoma (BTC) previously untreated with chemotherapy. Patients and methods Overall 38 consecutive patients who satisfied eligibility criteria (10 with gall-bladder carcinoma and 28 with bile duct carcinoma) were included in this phase II study. Median age was 61 years with median PS 1. Treatment included GEM 1000 mg/m2/week as 30 min i.v. on days 1 and 8, and CDDP 75–80 mg/m2 on day 1 with adequate hydration protocol and forced diuresis. Treatment was repeated every 3…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentPhases of clinical researchNeutropeniaDeoxycytidineGastroenterologyInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineCarcinomaHumansAgedChemotherapybusiness.industryHematologyMiddle Agedmedicine.diseaseGemcitabineGemcitabineSurgeryRegimenBile Duct NeoplasmsOncologyToxicityFemaleGallbladder NeoplasmsCisplatinbusinessProgressive diseasemedicine.drugAnnals of Oncology
researchProduct

Phase 2 Trial of Docetaxel, Gemcitabine, and Oxaliplatin Combination Chemotherapy in Platinum- and Paclitaxel-Pretreated Epithelial Ovarian Cancer

2009

Background: This phase 2 trial was designed to evaluate the efficacy and toxicity of a combination of docetaxel, gemcitabine, and oxaliplatin for platinum- and paclitaxel-pretreated epithelial ovarian cancer. Patients and Methods: Heavily pretreated patients (N = 30; median age, 61 years) received docetaxel, 55 mg/m2; gemcitabine, 500 mg/m2 (day 1); and oxaliplatin, 70 mg/m2 (day 2) biweekly. Twelve patients had platinum-sensitive disease, and 18 patients had platinum-resistant disease. Results: Median follow-up was 18.6 months. No differences in patient characteristics were observed between patients with carboplatinum-sensitive and carboplatinum-resistant disease. In patients with carbopla…

AdultOncologymedicine.medical_specialtyAdolescentOrganoplatinum CompoundsPaclitaxelAnemiaDocetaxelNeutropeniaDeoxycytidineYoung Adultchemistry.chemical_compoundRisk FactorsInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineFallopian Tube NeoplasmsHumansNeoplasm InvasivenessProspective StudiesPeritoneal NeoplasmsAgedNeoplasm StagingOvarian Neoplasmsbusiness.industryObstetrics and GynecologyCombination chemotherapyMiddle AgedPrognosismedicine.diseaseGemcitabineGemcitabineOxaliplatinOxaliplatinTreatment OutcomeOncologyDocetaxelPaclitaxelchemistryFemaleTaxoidsOvarian cancerbusinessmedicine.drugInternational Journal of Gynecological Cancer
researchProduct

Phase II trial of docetaxel and carboplatin in recurrent platinum-sensitive ovarian, peritoneal and tubal cancer

2007

Abstract Objective. Docetaxel and carboplatin are active in relapsed ovarian, peritoneal and tubal cancer. Recently, two prospective-randomized trials showed an advantage of carboplatin combination regimen with paclitaxel or gemcitabine over carboplatinum alone in platinum-sensitive cases. The question on the most effective combination with the best tolerable side effects still needs to be answered. Methods. Eligible patients had recurrent ovarian, peritoneal or tubal cancer (platinum-free interval >6 months), performance status 0–2 and normal bone marrow, renal and hepatic function. 25 patients (age 18–75 years) were enrolled into this phase II trial. Patients with debulking operation of r…

AdultOncologymedicine.medical_specialtyPopulationDocetaxelGastroenterologyDisease-Free SurvivalCarboplatinchemistry.chemical_compoundInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineFallopian Tube NeoplasmsHumanseducationPeritoneal NeoplasmsAgedOvarian Neoplasmseducation.field_of_studyPerformance statusbusiness.industryObstetrics and GynecologyCancerMiddle AgedDebulkingmedicine.diseaseGemcitabineCarboplatinRegimenOncologyDocetaxelchemistryDrug Resistance NeoplasmFemaleTaxoidsNeoplasm Recurrence Localbusinessmedicine.drugGynecologic Oncology
researchProduct

The impact of isolated lesions on white-matter fiber tracts in multiple sclerosis patients

2015

Infratentorial lesions have been assigned an equivalent weighting to supratentorial plaques in the new McDonald criteria for diagnosing multiple sclerosis. Moreover, their presence has been shown to have prognostic value for disability. However, their spatial distribution and impact on network damage is not well understood. As a preliminary step in this study, we mapped the overall infratentorial lesion pattern in relapsing–remitting multiple sclerosis patients (N = 317) using MRI, finding the pons (lesion density, 14.25/cm3) and peduncles (13.38/cm3) to be predilection sites for infratentorial lesions. Based on these results, 118 fiber bundles from 15 healthy controls and a subgroup of 23 …

AdultPathologymedicine.medical_specialtyWallerian degenerationCognitive Neurosciencelcsh:Computer applications to medicine. Medical informaticsArticlelcsh:RC346-429LesionWhite matterMultiple sclerosisMultiple Sclerosis Relapsing-RemittingNerve FibersLSAF left superior arcuate fasciculusFractional anisotropymedicineHumansRadiology Nuclear Medicine and imagingFA fractional anisotropyNAWM normal-appearing white matterLD lesion densitylcsh:Neurology. Diseases of the nervous systemEAE experimental autoimmune encephalomyelitisMD mean diffusivitybusiness.industryMultiple sclerosisWhite matterMcDonald criteriaMiddle Agedmedicine.diseaseRD radial diffusivitymedicine.anatomical_structureDiffusion tensor imagingNeurologylcsh:R858-859.7Neurology (clinical)Brainstemmedicine.symptomFunction and Dysfunction of the Nervous SystembusinessBrainstemAD axial diffusivityDiffusion MRIBrain StemICP inferior cerebellar peduncleFractional anisotropyNeuroImage: Clinical
researchProduct